Fig. 4From: An open label, non-controlled, multicentre, interventional trial to investigate the safety and efficacy of Canephron® N in the management of uncomplicated urinary tract infections (uUTIs)Kaplan-Meier curve visualizing the proportion of responders at each study day. Responder defined as symptoms dysuria, frequency and urgency not worse than mild (blue line) or absent (green line) (full analysis set, N = 125)Back to article page